About Bio+IT Platform

Pioneering the future of biotechnology through the seamless integration of wet lab expertise and AI-driven computational biology

Our Mission

To accelerate biotechnology innovation by creating the world's most advanced Bio+IT dual-engine platform, seamlessly integrating wet lab capabilities with AI-driven computational biology to solve humanity's greatest challenges in health, sustainability, and industrial biotechnology.

Our Vision

To become the global leader in AI-powered biotechnology, enabling breakthrough discoveries that transform industries and improve lives worldwide. We envision a future where biological systems are designed with precision, manufactured sustainably, and deployed at scale.

Our Journey

From startup to industry leader in biotechnology innovation

2019

Company Founded

Established with vision to bridge wet lab and dry lab biotechnology

Initial funding of $2M
2020

First AI Models

Launched protein structure prediction platform

10,000+ predictions completed
2021

Wet Lab Integration

Opened state-of-the-art biosynthesis facility

First commercial production
2022

Global Expansion

Established partnerships across 3 continents

50+ enterprise clients
2023

Platform Launch

Released integrated Bio+IT dual-engine platform

$25M Series B funding
2024

Market Leadership

Recognized as industry leader in AI-driven biotechnology

100+ patents filed

Leadership Team

Experienced leaders driving biotechnology innovation

DEC

Dr. Emily Chen

Chief Executive Officer

Former VP of R&D at Genentech, PhD Biochemistry from MIT

Expertise: Biotechnology commercialization, strategic partnerships
Experience: 15+ years in biotech industry
DMR

Dr. Michael Rodriguez

Chief Technology Officer

Ex-Google DeepMind researcher, PhD Computer Science from Stanford

Expertise: AI/ML for biological systems, computational biology
Experience: 12+ years in AI research
DSK

Dr. Sarah Kim

Chief Scientific Officer

Former Principal Scientist at Novozymes, PhD Chemical Engineering

Expertise: Enzyme engineering, industrial biotechnology
Experience: 18+ years in enzyme development
JT

James Thompson

Chief Financial Officer

Former CFO at Zymergen, MBA from Wharton

Expertise: Biotech finance, strategic planning, M&A
Experience: 20+ years in finance

Our Values

Core principles that guide our work and culture

Scientific Excellence

Commitment to rigorous research and peer-reviewed validation

Innovation First

Pioneering breakthrough technologies that transform industries

Collaborative Spirit

Building partnerships that accelerate global biotechnology advancement

Sustainable Impact

Developing solutions that benefit both business and environment

Global Presence

Our locations around the world

S

San Francisco, CA

Global Headquarters

123 Biotech Boulevard, San Francisco, CA 94158

Focus: R&D, AI Development, Business Operations
Employees: 150
B

Boston, MA

Research Center

456 Innovation Drive, Cambridge, MA 02142

Focus: Wet Lab Research, Protein Engineering
Employees: 85
S

Singapore

Asia-Pacific Hub

789 Science Park Road, Singapore 117684

Focus: Manufacturing, Regional Partnerships
Employees: 60
L

London, UK

European Office

321 Tech City Lane, London EC1V 2NX

Focus: Business Development, Regulatory Affairs
Employees: 35